PodParley PodParley
PodParley
Genzyme Jumps Into Rapidly Growing Business Of Genetic Medicines episode artwork

EPISODE · Jan 13, 2014 · 1 MIN

Genzyme Jumps Into Rapidly Growing Business Of Genetic Medicines

from New England Business · host Anthony Silva

Genzyme is spending $700 million dollars to buy a chunk of Alnylam Pharmaceuticals of Cambridge.

Episode metadata supplied by the publisher feed · Published Jan 13, 2014

Embed this episode

NOW PLAYING

Genzyme Jumps Into Rapidly Growing Business Of Genetic Medicines

0:00 1:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of New England Business?

This episode is 1 minute long.

When was this New England Business episode published?

This episode was published on January 13, 2014.

Can I download this New England Business episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!